impactCancer Spring 2015
I’m proud to report that, after many years of planning, design and construction, our new Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is open and operating as one of the world’s most advanced facilities for science-based cancer care.
We officially opened the new James on Dec. 15, 2014, following a superbly orchestrated Dec. 12-14 weekend move of 221 patients from the original James to its transformational successor – a 21-floor, 1.1-million-square-foot, 306-bed hospital that stands as a beacon of hope to all cancer patients and families who turn to us for help.
One major reason we consider it transformational is that it is designed to accelerate the translation of discoveries to innovative patient care by placing researchers and clinicians in closer working proximity than ever before. Each inpatient floor has either a wet or a dry research lab so researchers and clinicians can collaborate closely and see firsthand how their work benefits our patients.
You can read more about our pre-opening celebrations, the big move-in weekend and the new hospital itself in this issue of impactCancer, which also offers a look at the OSUCCC – James’ Drug Development Institute (DDI). Utilizing the vast array of resources available at Ohio State, the DDI has established an efficient industry approach to developing cancer-fighting drugs that will bring us ever closer to realizing our shared vision of a cancer-free world.
Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute